Anmelden Kostenlos registrieren

Beam Therapeutics Quick ratio

Was ist das Quick ratio von Beam Therapeutics?

Quick ratio von Beam Therapeutics Inc. ist 5.81

Was ist die Definition von Quick ratio?



Einzugsliquidität (Quick Ratio) ist die Liquiditätsquote, die die Fähigkeit eines Unternehmens misst, seine kurzfristigen Vermögenswerte zur sofortigen Erfüllung seiner kurzfristigen Verpflichtungen einzusetzen.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Beam Therapeutics

Was macht Beam Therapeutics?

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Unternehmen mit quick ratio ähnlich Beam Therapeutics